MET and cancer: Hepatocyte growth factor (HGF), via stimulation of its cognate receptor c-MET, and activation of the downstream effector components (MAPK, STAT, PI3K-AKT cascades and NF-κB), increases the survival, motility and proliferation of several cell types of cancer cells, including melanoma cells.